SCHEMBL26629784

SCHEMBL26629784

CNc1cc2c(cc1OC)CCN(C)C2

nearest known ligand 0.73

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 2/20 0.73
▸ MAOB P27338 2/20 0.73
▸ SLC6A4 P31645 1/20 0.73
▸ CHRNA7 P36544 2/20 0.52
▸ MAP4K1 Q92918 5/20 0.52
▸ DRD1 P21728 3/20 0.51
▸ DRD5 P21918 3/20 0.51
▸ DRD4 P21917 2/20 0.51
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ DRD2 P14416 2/20 0.47
▸ DRD3 P35462 2/20 0.47
▸ HTR2A P28223 1/20 0.46
▸ HTR2C P28335 1/20 0.46
▸ HTR6 P50406 1/20 0.46
▸ PDE4D Q08499 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30634713 0.85 MAOB (1.00) MAOAMAOBSLC6A4CHRNA7DRD1
SCHEMBL5525085 0.85 MAOB (1.00) MAOAMAOBSLC6A4CHRNA7DRD1
Hydrochloric Acid SCHEMBL20854708 0.83 MAOB (0.96) MAOAMAOBSLC6A4CHRNA7DRD1
Hydrochloric Acid SCHEMBL30634715 0.83 MAOB (0.96) MAOAMAOBSLC6A4CHRNA7DRD1
SCHEMBL24394226 0.82 MAOA (0.65) MAOAMAOBSLC6A4CHRNA7MAP4K1
SCHEMBL29843393 0.79 MAOA (0.60) MAOAMAOBSLC6A4CHRNA7MAP4K1
SCHEMBL24420537 0.79 MAOA (0.50) MAOAMAOBSLC6A4CHRNA7MAP4K1
SCHEMBL24746023 0.79 MAOA (0.80) MAOAMAOBSLC6A4CHRNA7MAP4K1
SCHEMBL19815866 0.78 MAPT (0.46) MAOAMAOBSLC6A4CHRNA7MEN1
SCHEMBL20939758 0.78 MAOB (0.77) MAOAMAOBSLC6A4CHRNA7DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339896-A1 HPK1 INHIBITORS AND USES THEREOF REGOR PHARMACEUTICALS, INC. 2023-10-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339896-A1 HPK1 INHIBITORS AND USES THEREOF HIPK1, MAPKAPK5, MLKL MAOA 4479/4885MAOB 4521/4885SLC6A4 3814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback